A 6 mg dose of Biogen’s experimental Alzheimer’s disease drug significantly reduced beta amyloid plaque in the brain but failed…
Read MoreA 6 mg dose of Biogen’s experimental Alzheimer’s disease drug significantly reduced beta amyloid plaque in the brain but failed…
Read MoreDanish pharmaceutical group Lundbeck said on Monday that it hopes to launch a new Alzheimer’s medicine in 2017 in what…
Read MoreDiet plays a role in many health conditions, but a new study has strengthened researchers’ understanding of the connection between…
Read MorePeople with two parents suffering from Alzheimer’s disease may show signs of the disease in brain scans years before developing…
Read More